M. Robyn Andersen, PhD

RobynAndersen

M. Robyn Andersen, PhD
Fred Hutchinson Cancer Research Center

Use of counter-indicated CAM treatments by ovarian cancer patients

It has been estimated that 44% of ovarian cancer patients use Complementary and Alternative Medicine (CAM). While many CAM treatments are safe, several that may be commonly used are contra-indicated during active conventional treatment. Dr. Anderson’s study seeks to conduct a cross-sectional survey of 300 women in treatment that would include detailed analyses of women’s stage of disease and use of conventional and CAM treatments. This would allow exploration of issues associated with counter-indicated CAM use by ovarian cancer patients.